Stocks · Healthcare · Biotechnology
LENZ Therapeutics, Inc. LENZ
$3.58 -5.54% Close, Oct 2, 2026 · NASDAQ · Market cap $112.2M
Strong growthWeak trendExpensive vs sectorHigh risk
Next earnings report: Nov 4, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Revenue over the last four quarters was $21.5M, up 329.5% from a year earlier.
- Operating margin widened to -631.7% from -1239.2% a year earlier.
- The stock is 93% below its highest close of the past year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 5%
- Revenue growth, 3-year CAGRBottom 46%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 20%
- Gross marginTop 19%
- Operating marginBottom 15%
- Accruals (lower is better)Bottom 43%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 4%
- Free-cash-flow yieldBottom 3%
- EBITDA / enterprise valueBottom 3%
- Sales / enterprise valueTop 48%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 1%
- 6-month returnBottom 2%
- 1-year return vs S&P 500Bottom 1%
- Distance from 52-week highBottom 1%
- Trend checklist (0–4)Bottom 14%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 31%
- Consecutive EPS beatsBottom 49%
- Share of analysts rating BuyTop 45%
- Upside to consensus price targetTop 38%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 28%
- Maximum drawdown, 3 yearsBottom 10%
- Beta vs S&P 500 (lower is better)Bottom 22%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Gross margin | 98.9% | 90.1% | ↓ |
| Operating margin | -1239.2% | -631.7% | ↑ |
| FCF margin | -958.0% | -532.8% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 329.5% | — | Top 5% | |
| Gross margin | 90.1% | 98.9% | ↓ | Top 19% |
| Operating margin | -631.7% | -1239.2% | ↑ | Bottom 15% |
| Net margin | -586.7% | -1048.0% | ↑ | — |
| Free-cash-flow margin | -532.8% | -958.0% | ↑ | — |
| Return on invested capital | -61.8% | — | Bottom 20% | |
| Revenue growth, 3-year CAGR | 8.4% | — | Bottom 46% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -5.1%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 54.1%
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -110.13%
- Shareholder yield
- -110.13%
- Share count change, 1 year
- +11.7%
- Share count change, 3-year CAGR
- +57.0%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 11, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 1
- Beats in the last 8 reports
- 5 of 8
- Average EPS surprise, last 4
- -8.2%
- Average 2-day reaction, last 8
- -4.1%
- Positive 20 days after report
- 3 of 8
Analysts
- Consensus price target
- $7.00
- Target vs current price
- +95.5%
- Analysts with a rating
- 5
- Share rating Buy or Strong Buy
- 80%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 11, 2026 | +2.9% | -2.8% | -10.6% | -0.6% | — |
| May 11, 2026 | -20.0% | -0.7% | -27.0% | -33.2% | -47.6% |
| Mar 24, 2026 | -27.5% | -17.9% | -24.6% | -10.3% | -42.4% |
| Nov 5, 2025 | +11.9% | -23.5% | -5.7% | -0.2% | -41.9% |
| Jul 30, 2025 | +8.6% | -2.9% | -3.8% | +22.0% | +3.3% |
| May 7, 2025 | +3.6% | -2.1% | +11.9% | +12.7% | +15.7% |
| Mar 19, 2025 | -9.5% | +4.6% | +8.3% | -2.1% | +21.2% |
| Nov 6, 2024 | +17.4% | +12.5% | +30.0% | +25.1% | -9.3% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 11, 2026 | -$1.02 | -$1.05 | +2.9% | $5.5M |
| May 11, 2026 | -$1.32 | -$1.10 | -20.0% | $1.9M |
| Mar 24, 2026 | -$1.16 | -$0.91 | -27.5% | $1.6M |
| Nov 5, 2025 | -$0.59 | -$0.67 | +11.9% | $12.5M |
| Jul 30, 2025 | -$0.53 | -$0.58 | +8.6% | $5.0M |
| May 7, 2025 | -$0.53 | -$0.55 | +3.6% | — |
| Mar 19, 2025 | -$0.46 | -$0.42 | -9.5% | — |
| Nov 6, 2024 | -$0.38 | -$0.46 | +17.4% | — |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 4.11× | — | — | Top 48% |
| Free-cash-flow yield | -101.93% | — | — | Bottom 3% |
| Earnings yield | -114.25% | — | — | Bottom 4% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -9.1%
- 200-day average slope (20 days)
- -19.6%
- Distance from 50-day average
- -25.3%
- Distance from 200-day average
- -61.7%
- RSI (14)
- 29.4
- Relative volume
- 1.50×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 69.9%
- Volatility vs own 5-year history
- 47th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.75
- Correlation with S&P 500
- 0.33
- Current drawdown from 1-year high
- -92.7%
- Maximum drawdown, 3 years
- -92.7%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Jun 30, 2021 | Oct 2, 2026 | -97.5% | 1320 days | Not yet recovered |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $112.2M
- EPS, diluted (TTM)
- -$4.09
- Revenue (TTM)
- $21.5M
- 52-week range
- $3.51 – $50.40
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $0 | $15.0M | $0 | $0 | $19.1M |
| Gross profit | -$734,000 | $15.0M | $0 | -$58,000 | $18.4M |
| Operating income | -$60.4M | -$10.5M | -$72.4M | -$58.6M | -$91.1M |
| Net income | -$70.8M | -$10.8M | -$70.0M | -$49.8M | -$82.1M |
| EPS (diluted) | -$8.54 | -$12.89 | -$15.30 | -$2.34 | -$2.85 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $5.0M | $12.5M | $1.6M | $1.9M | $5.5M |
| Net income | -$10.2M | -$12.7M | -$14.6M | -$14.9M | -$16.7M | -$35.9M | -$41.5M | -$31.9M |
| EPS (diluted) | -$0.38 | -$0.46 | -$0.53 | -$0.53 | -$0.59 | -$1.16 | -$1.32 | -$1.02 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$52.9M | -$88.0M | -$60.4M | -$59.4M | -$69.2M |
| Capital expenditure | -$5.7M | -$6.6M | -$30,000 | -$468,000 | -$827,000 |
| Free cash flow | -$58.6M | -$94.6M | -$60.4M | -$59.9M | -$70.0M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $417.2M | $597,000 | $203,000 | $79.5M | $149.7M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $220.0M
- Total assets
- $236.6M
- Total liabilities
- $17.3M
- Total debt
- $122,000
- Net debt
- -$24.1M
- Shareholders’ equity
- $219.3M
As of Jun 30, 2026 (filed Aug 11, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Mar 22, 2024 | $1.03 | — |
| Mar 15, 2024 | $1.03 | — |
Short interest
- Shares sold short
- 10,629,972
- Days to cover
- 14.55
- Change vs previous report
- -2.3%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Mar 22, 2024
- 1-for-7